Answers are grounded in this paper and cite their sources.
Purpose: We aimed to assess the rule of plasma miR-30b- 5P as a biomarker for early diagnosis of breast cancer (BrC).Patients and Methods: This case control study was conducted on 50 participants, females, newly diagnosed with breast cancer before receiving any treatment. Subjects were categorized into two groups: Group I (patient group): 35 adults, their age was (53.6 ± 12.20) years, are newly diagnosed BrC before any treatment and Group II (control group): 15 subjects, their age was (47.7 ± 9.59) years, apparently healthy matching age and sex with patients.Results: There is statistically significant difference regarding presence of lesions by Mammogram when compare cases with control (p < .001). And there is a significant elevation in the expression of miR - 30 b - 5p when comparing cases with control group (p < .001).Conclusion: Plasma miR-30b-5P can be used as a biomarker for early diagnosis of BrC.
No takes yet. Share an insight, caveat, or question.
Shafie et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: